Researchers also highlighted the significance of TTNT-D as a real-world measure of treatment efficacy, noting it provides ...

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer that affects white blood cells. Survival rates tend to be high, but these may vary. Leukemia is a type of cancer involving human blood ...

Chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) are two different types of leukemia. Both conditions affect white blood cells. CML affects a type of white blood cell called ...

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. It can progress slowly and may not cause many symptoms. Although it is treatable, it’s not ...

For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...

Imbruvica (ibrutinib) is a brand-name drug that’s prescribed for chronic lymphocytic leukemia (CLL). This article covers topics such as side effects, dosage, and how Imbruvica works. Imbruvica ...

The global leukemia therapeutics treatment market is expected to grow at a CAGR of 6.6% during the forecast period (2025–2035). Factors such as the rising prevalence of leukemia, increasing adoption ...

The 5-year relative survival rate for CML is 70%. Chronic lymphocytic leukemia (CLL) is most likely to affect people over age 55 years. It’s very rarely seen in children. According to the NCI ...

SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

During a Case-Based Roundtable® event, Ryan W. Jacobs, MD, discussed a patient who received 2 prior lines of therapy for ...

Edward Ratner has lived with chronic lymphocytic leukemia for a decade. Here, the Minneapolis doctor shares his rules for success.